| UniProt ID | ALG9_HUMAN | |
|---|---|---|
| UniProt AC | Q9H6U8 | |
| Protein Name | Alpha-1,2-mannosyltransferase ALG9 {ECO:0000305} | |
| Gene Name | ALG9 {ECO:0000312|HGNC:HGNC:15672} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 611 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
| Protein Description | Catalyzes the transfer of mannose from Dol-P-Man to lipid-linked oligosaccharides.. | |
| Protein Sequence | MASRGARQRLKGSGASSGDTAPAADKLRELLGSREAGGAEHRTELSGNKAGQVWAPEGSTAFKCLLSARLCAALLSNISDCDETFNYWEPTHYLIYGEGFQTWEYSPAYAIRSYAYLLLHAWPAAFHARILQTNKILVFYFLRCLLAFVSCICELYFYKAVCKKFGLHVSRMMLAFLVLSTGMFCSSSAFLPSSFCMYTTLIAMTGWYMDKTSIAVLGVAAGAILGWPFSAALGLPIAFDLLVMKHRWKSFFHWSLMALILFLVPVVVIDSYYYGKLVIAPLNIVLYNVFTPHGPDLYGTEPWYFYLINGFLNFNVAFALALLVLPLTSLMEYLLQRFHVQNLGHPYWLTLAPMYIWFIIFFIQPHKEERFLFPVYPLICLCGAVALSALQKCYHFVFQRYRLEHYTVTSNWLALGTVFLFGLLSFSRSVALFRGYHGPLDLYPEFYRIATDPTIHTVPEGRPVNVCVGKEWYRFPSSFLLPDNWQLQFIPSEFRGQLPKPFAEGPLATRIVPTDMNDQNLEEPSRYIDISKCHYLVDLDTMRETPREPKYSSNKEEWISLAYRPFLDASRSSKLLRAFYVPFLSDQYTVYVNYTILKPRKAKQIRKKSGG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Methylation | RGARQRLKGSGASSG HHHHHHHCCCCCCCC | 53.90 | - | |
| 13 | Phosphorylation | ARQRLKGSGASSGDT HHHHHCCCCCCCCCC | 29.60 | 26657352 | |
| 16 | Phosphorylation | RLKGSGASSGDTAPA HHCCCCCCCCCCCCH | 38.08 | 29255136 | |
| 17 | Phosphorylation | LKGSGASSGDTAPAA HCCCCCCCCCCCCHH | 39.90 | 22798277 | |
| 26 | 2-Hydroxyisobutyrylation | DTAPAADKLRELLGS CCCCHHHHHHHHHCC | 44.72 | - | |
| 26 (in isoform 1) | Ubiquitination | - | 44.72 | 21906983 | |
| 26 | Ubiquitination | DTAPAADKLRELLGS CCCCHHHHHHHHHCC | 44.72 | 21906983 | |
| 49 (in isoform 1) | Ubiquitination | - | 58.37 | 21906983 | |
| 49 | Ubiquitination | RTELSGNKAGQVWAP CCCCCCCCCCCEECC | 58.37 | 2190698 | |
| 49 (in isoform 3) | Ubiquitination | - | 58.37 | - | |
| 63 | Ubiquitination | PEGSTAFKCLLSARL CCCCHHHHHHHHHHH | 22.85 | - | |
| 63 (in isoform 3) | Ubiquitination | - | 22.85 | - | |
| 67 | Phosphorylation | TAFKCLLSARLCAAL HHHHHHHHHHHHHHH | 9.82 | 24719451 | |
| 77 | N-linked_Glycosylation | LCAALLSNISDCDET HHHHHHHCCCCCCHH | 37.44 | UniProtKB CARBOHYD | |
| 180 | Phosphorylation | MLAFLVLSTGMFCSS HHHHHHHHCCCCCCC | 18.55 | 24043423 | |
| 181 | Phosphorylation | LAFLVLSTGMFCSSS HHHHHHHCCCCCCCC | 28.62 | 24043423 | |
| 186 | Phosphorylation | LSTGMFCSSSAFLPS HHCCCCCCCCCCCCH | 18.96 | 24043423 | |
| 187 | Phosphorylation | STGMFCSSSAFLPSS HCCCCCCCCCCCCHH | 27.20 | 24043423 | |
| 188 | Phosphorylation | TGMFCSSSAFLPSSF CCCCCCCCCCCCHHH | 13.52 | 24043423 | |
| 193 | Phosphorylation | SSSAFLPSSFCMYTT CCCCCCCHHHHHHHH | 37.89 | 24043423 | |
| 194 | Phosphorylation | SSAFLPSSFCMYTTL CCCCCCHHHHHHHHH | 22.11 | 24043423 | |
| 198 | Phosphorylation | LPSSFCMYTTLIAMT CCHHHHHHHHHHHHH | 9.58 | 24043423 | |
| 199 | Phosphorylation | PSSFCMYTTLIAMTG CHHHHHHHHHHHHHC | 6.56 | 24043423 | |
| 200 | Phosphorylation | SSFCMYTTLIAMTGW HHHHHHHHHHHHHCC | 9.93 | 24043423 | |
| 205 | Phosphorylation | YTTLIAMTGWYMDKT HHHHHHHHCCCCCHH | 18.62 | 24043423 | |
| 208 | Phosphorylation | LIAMTGWYMDKTSIA HHHHHCCCCCHHHHH | 9.22 | 24043423 | |
| 259 (in isoform 3) | Ubiquitination | - | 1.86 | 21906983 | |
| 282 (in isoform 3) | Ubiquitination | - | 5.16 | 21906983 | |
| 343 | Ubiquitination | QRFHVQNLGHPYWLT HHHCHHCCCCCHHHH | 3.59 | 21963094 | |
| 359 | Ubiquitination | APMYIWFIIFFIQPH HHHHHHHHHHHCCCC | 1.29 | 21963094 | |
| 384 | Ubiquitination | PLICLCGAVALSALQ HHHHHHHHHHHHHHH | 5.17 | 21963094 | |
| 391 | Ubiquitination | AVALSALQKCYHFVF HHHHHHHHHHHHHHH | 33.23 | 21963094 | |
| 451 | Phosphorylation | PEFYRIATDPTIHTV HHHHHHCCCCCCEEC | 39.89 | 12302391 | |
| 457 | Phosphorylation | ATDPTIHTVPEGRPV CCCCCCEECCCCCCE | 33.63 | 12302401 | |
| 470 | Ubiquitination | PVNVCVGKEWYRFPS CEEEEECCCEEECCC | 25.36 | - | |
| 477 (in isoform 3) | Ubiquitination | - | 30.89 | - | |
| 514 | Ubiquitination | LATRIVPTDMNDQNL CCEEECCCCCCCCCC | 36.67 | 21963094 | |
| 521 | Ubiquitination | TDMNDQNLEEPSRYI CCCCCCCCCCCHHEE | 7.01 | 21963094 | |
| 525 | Phosphorylation | DQNLEEPSRYIDISK CCCCCCCHHEEEHHH | 40.78 | 22210691 | |
| 532 | Ubiquitination | SRYIDISKCHYLVDL HHEEEHHHCCEEEEH | 25.93 | - | |
| 539 (in isoform 3) | Ubiquitination | - | 4.62 | - | |
| 551 | Phosphorylation | ETPREPKYSSNKEEW CCCCCCCCCCCHHHH | 28.22 | 28258704 | |
| 555 | Ubiquitination | EPKYSSNKEEWISLA CCCCCCCHHHHHHHH | 59.98 | 21963094 | |
| 562 (in isoform 3) | Ubiquitination | - | 7.47 | - | |
| 562 | Ubiquitination | KEEWISLAYRPFLDA HHHHHHHHHHHHHCC | 7.47 | 21963094 | |
| 593 | N-linked_Glycosylation | DQYTVYVNYTILKPR CCEEEEEEEEEECCH | 15.56 | UniProtKB CARBOHYD |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ALG9_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ALG9_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ALG9_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| BHMT1_HUMAN | BHMT | physical | 21988832 | |
| COR1C_HUMAN | CORO1C | physical | 26344197 | |
| HNRPF_HUMAN | HNRNPF | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00118 | Congenital disorders of glycosylation (CDG) type I | |||||
| OMIM Disease | ||||||
| Note=A chromosomal aberration involving ALG9 is found in a family with bipolar affective disorder. Translocation t(9 | ||||||
| 11)(p24 | ||||||
| q23). However, common variations in ALG9 do not play a major role in predisposition to bipolar affective disorder. | ||||||
| 608776 | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...